Symptomatic 3rd and 4th degree haemorrhoids Circulatory System Haemorrhoids
Conditions
Interventions
Patients will be randomised to undergo haemorrhoidectomy with methylene blue and marcaine 0.5% or marcaine 0.5% only alone intradermal injections using sealed envelopes. A standard medication package
Sponsors
Khoo Teck Puat Hospital (Singapore)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Fresh cases of symptomatic 3rd and 4th degree haemorrhoids 2. Aged between 21 and 80 years of age 3. Able to give informed consent
Exclusion criteria
Exclusion criteria: 1. Undergoing combined procedures for fissures or fistulae 2. Do not give informed consent 3. Allergy reactions to diclofenac, Daflon®, Fybogel®, methylene blue, paracetamol 4. Pregnant or breast feeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain, assessed using a 11-point visual analogue pain score from 0 to 10 (0 = no pain; 10 = unbearable pain). Participants will be asked to record their maximum pain score daily before retiring. 2. Total number of analgesics tablets patients have taken for the day | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications which include: 1. Pain requiring unscheduled stay or unscheduled return 2. Urinary retention 3. Delayed bleeding 4. Discharge 5. Itching 6. Skin reaction to methylene blue | — |
Countries
Singapore
Outcome results
None listed